Literature DB >> 35121877

Chronic liver disease enables gut Enterococcus faecalis colonization to promote liver carcinogenesis.

Noriho Iida1, Eishiro Mizukoshi2, Tatsuya Yamashita1, Masahiro Yutani3, Jun Seishima1, Ziyu Wang1, Kuniaki Arai1, Hikari Okada1, Taro Yamashita1, Yoshio Sakai1, Yusuke Masuo4, Rina Agustina4, Yukio Kato4, Yukako Fujinaga3, Masanobu Oshima5, Masao Honda1, François Lebreton6, Michael S Gilmore6, Shuichi Kaneko1.   

Abstract

Gut dysbiosis is observed in chronic hepatobiliary diseases and is frequently associated with liver carcinogenesis; however, the extent and specific mechanisms triggered by alterations in the microbiota mediating tumorigenesis in these patients remain unclear. Here we show that Enterococcus faecalis is abundant in the microbiota of patients with hepatitis C virus-related chronic liver disease. Xenotransplantation of gut microbiota from these patients increased the number of spontaneous liver tumors in mice and enhanced susceptibility to liver carcinogens. Hepatic colonization by gelE-positive E. faecalis increased liver expression of proliferative genes in a TLR4-Myd88-dependent manner, leading to liver tumorigenesis. Moreover, decreased fecal deoxycholic acid levels were associated with colonization by E. faecalis. Overall, these data identify E. faecalis as a key promoter of liver carcinogenesis.
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 35121877     DOI: 10.1038/s43018-021-00251-3

Source DB:  PubMed          Journal:  Nat Cancer        ISSN: 2662-1347


  47 in total

Review 1.  Cancer and the microbiota.

Authors:  Wendy S Garrett
Journal:  Science       Date:  2015-04-03       Impact factor: 47.728

2.  Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.

Authors:  Sujan Ravi; Page Axley; DeAnn Jones; Sudha Kodali; Heather Simpson; Brendan M McGuire; Ashwani K Singal
Journal:  Gastroenterology       Date:  2017-02-02       Impact factor: 22.682

3.  Tracing the Enterococci from Paleozoic Origins to the Hospital.

Authors:  François Lebreton; Abigail L Manson; Jose T Saavedra; Timothy J Straub; Ashlee M Earl; Michael S Gilmore
Journal:  Cell       Date:  2017-05-11       Impact factor: 41.582

4.  The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study.

Authors:  Darrick K Li; Yanjie Ren; Daniel S Fierer; Stephanie Rutledge; Obaid S Shaikh; Vincent Lo Re; Tracey Simon; Abdul-Badi Abou-Samra; Raymond T Chung; Adeel A Butt
Journal:  Hepatology       Date:  2018-04-19       Impact factor: 17.425

5.  Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.

Authors:  Dianne H Dapito; Ali Mencin; Geum-Youn Gwak; Jean-Philippe Pradere; Myoung-Kuk Jang; Ingmar Mederacke; Jorge M Caviglia; Hossein Khiabanian; Adebowale Adeyemi; Ramon Bataller; Jay H Lefkowitch; Maureen Bower; Richard Friedman; R Balfour Sartor; Raul Rabadan; Robert F Schwabe
Journal:  Cancer Cell       Date:  2012-04-17       Impact factor: 31.743

6.  Cospeciation of gut microbiota with hominids.

Authors:  Andrew H Moeller; Alejandro Caro-Quintero; Deus Mjungu; Alexander V Georgiev; Elizabeth V Lonsdorf; Martin N Muller; Anne E Pusey; Martine Peeters; Beatrice H Hahn; Howard Ochman
Journal:  Science       Date:  2016-07-22       Impact factor: 47.728

7.  Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals.

Authors:  Fabio Conti; Federica Buonfiglioli; Alessandra Scuteri; Cristina Crespi; Luigi Bolondi; Paolo Caraceni; Francesco Giuseppe Foschi; Marco Lenzi; Giuseppe Mazzella; Gabriella Verucchi; Pietro Andreone; Stefano Brillanti
Journal:  J Hepatol       Date:  2016-06-24       Impact factor: 25.083

8.  The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.

Authors:  Jérôme Boursier; Olaf Mueller; Matthieu Barret; Mariana Machado; Lionel Fizanne; Felix Araujo-Perez; Cynthia D Guy; Patrick C Seed; John F Rawls; Lawrence A David; Gilles Hunault; Frédéric Oberti; Paul Calès; Anna Mae Diehl
Journal:  Hepatology       Date:  2016-01-13       Impact factor: 17.425

9.  Alterations of the human gut microbiome in liver cirrhosis.

Authors:  Nan Qin; Fengling Yang; Ang Li; Edi Prifti; Yanfei Chen; Li Shao; Jing Guo; Emmanuelle Le Chatelier; Jian Yao; Lingjiao Wu; Jiawei Zhou; Shujun Ni; Lin Liu; Nicolas Pons; Jean Michel Batto; Sean P Kennedy; Pierre Leonard; Chunhui Yuan; Wenchao Ding; Yuanting Chen; Xinjun Hu; Beiwen Zheng; Guirong Qian; Wei Xu; S Dusko Ehrlich; Shusen Zheng; Lanjuan Li
Journal:  Nature       Date:  2014-07-23       Impact factor: 49.962

Review 10.  Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals.

Authors:  Thomas F Baumert; Frank Jühling; Atsushi Ono; Yujin Hoshida
Journal:  BMC Med       Date:  2017-03-14       Impact factor: 11.150

View more
  3 in total

1.  Adaptation of the gut pathobiont Enterococcus faecalis to deoxycholate and taurocholate bile acids.

Authors:  F Repoila; F Le Bohec; C Guérin; C Lacoux; S Tiwari; A K Jaiswal; M Passos Santana; S P Kennedy; B Quinquis; D Rainteau; V Juillard; S Furlan; P Bouloc; P Nicolas; A Miyoshi; V Azevedo; P Serror
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

2.  Probiotic Lactobacilli ameliorate alcohol-induced hepatic damage via gut microbial alteration.

Authors:  Juseok Kim; Seong Woo Ahn; Joon Yong Kim; Tae Woong Whon; Seul Ki Lim; Byung Hee Ryu; Nam Soo Han; Hak-Jong Choi; Seong Woon Roh; Se Hee Lee
Journal:  Front Microbiol       Date:  2022-08-18       Impact factor: 6.064

3.  Elevation of enterococcus-specific antibodies associated with bacterial translocation is predictive of survival rate in chronic liver disease.

Authors:  Motoh Iwasa; Akiko Eguchi; Yasuyuki Tamai; Ryuta Shigefuku; Ryo Nakagawa; Hiroshi Hasegawa; Jumpei Kondo; Masayuki Morikawa; Eiji Miyoshi; Hayato Nakagawa
Journal:  Front Med (Lausanne)       Date:  2022-08-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.